Dashboard
Manage Tickers

OVID


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reported-earlier-ovid-therapeutics-announces-topline-results-from-its-phase-1-healthy-volunteer-study-evaluating-the-safety-tolerability-pharmacokinetic-and-pharmacodynamic-activity-of-ov329-a-next-generation-gaba-at-inhibitor-being-developed-for-drug-resistant-epilepsies-advancing-to-phase-2a-for-drug-resistant-epilepsy
Reported Earlier: Ovid Therapeutics Announ...
10/03/2025 14:50:22

An expansive biomarker study confirmed OV329 delivered statistically significant inhibition of GABA-AT as measured across multi...

reported-earlier-ovid-therapeutics-has-entered-into-a-securities-purchase-agreement-for-a-private-investment-in-public-equity-financing-that-is-expected-to-result-in-gross-proceeds-of-up-to-175m-to-advance-brain-disease-therapies
Reported Earlier: Ovid Therapeutics Has En...
10/03/2025 14:47:54

Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain co...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/03/2025 12:08:34

ovid-therapeutics-regains-compliance-with-nasdaq
Ovid Therapeutics Regains Compliance With ...
09/16/2025 12:14:59

-SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/13/2025 21:06:15

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/13/2025 17:06:22

ovid-therapeutics-q2-eps-006-beats-016-estimate-sales-6272m-beat-76667k-estimate
Ovid Therapeutics Q2 EPS $(0.06) Beats $(0...
08/13/2025 12:13:06

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
07/21/2025 21:06:05

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
07/17/2025 17:06:01

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
06/27/2025 21:05:51

ovid-therapeutics-enters-agreement-with-immedica-pharma-ab-immedica-to-pay-7m-in-cash-to-acquire-100-of-royalty-ganaxolone-rights-held-by-ovid
Ovid Therapeutics Enters Agreement with Im...
06/25/2025 12:09:26

hc-wainwright--co-maintains-buy-on-ovid-therapeutics-lowers-price-target-to-15
HC Wainwright & Co. Maintains Buy on Ovid ...
05/27/2025 11:01:41

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Ovid Therapeutics (NASDAQ:OVID) with a Buy and lowers the price...

ovid-therapeutics-q1-eps-014-inline-sales-13000k-beat-5000k-estimate
Ovid Therapeutics Q1 EPS $(0.14), Inline, ...
05/13/2025 12:10:38

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This i...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
04/24/2025 21:05:49

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
04/23/2025 21:05:54

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/09/2025 12:07:29

btig-maintains-buy-on-ovid-therapeutics-lowers-price-target-to-4
BTIG Maintains Buy on Ovid Therapeutics, L...
03/24/2025 13:28:39

BTIG analyst Thomas Shrader maintains Ovid Therapeutics (NASDAQ:OVID) with a Buy and lowers the price target from $5 to $4.

wedbush-maintains-outperform-on-ovid-therapeutics-lowers-price-target-to-3
Wedbush Maintains Outperform on Ovid Thera...
03/12/2025 14:27:05

Wedbush analyst Laura Chico maintains Ovid Therapeutics (NASDAQ:OVID) with a Outperform and lowers the price target from $4 ...

ovid-therapeutics-q4-2024-gaap-eps-013-beats-016-estimate-sales-76k-miss-189286k-estimate
Ovid Therapeutics Q4 2024 GAAP EPS $(0.13)...
03/11/2025 12:13:14

oppenheimer-upgrades-ovid-therapeutics-to-outperform-announces-4-price-target
Oppenheimer Upgrades Ovid Therapeutics to ...
01/29/2025 18:04:49

Oppenheimer analyst Francois Brisebois upgrades Ovid Therapeutics (NASDAQ:OVID) from Perform to Outperform and announces $4 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION